Thursday, 21 Sep 2023

Home » Health News » Trial demonstrates one-year progression-free survival in 94% of patients with stage 3 or 4 classic Hodgkin lymphoma

Trial demonstrates one-year progression-free survival in 94% of patients with stage 3 or 4 classic Hodgkin lymphoma

05/06/2023

cancer
Source: Read Full Article

Related posts:
  1. COVID-19: Pfizer shot appears to protect against UK variant
  2. Study shows people infected with Omicron may be less susceptible to Delta variant
  3. Gran, 90, shares what she owes to looking 20 years younger